Growth factor delivery from electrospun materials

Journal of Biomaterials and Tissue Engineering

Volumn 1, Issue 2, 2011, Pages 129-138

  Briggs, Tonye ^a   Arinzeh, Treena Livingston ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Electrospun material; Fiber; Growth factor; Scaffold; Tissue engineering

Indexed keywords

EID: 84889067936     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2011.1019     Document Type: Review

References (74)

1. J. M. Taboas, C. Kuo, K. G. T. Huang and R. S. Tuan, J. J. Mao, G. Vunjak-Novakovic, A. G. Mikos, and A. Atala (eds.), Translational Engineering and Regenerative Medicine, Artech House, Norwood (2008).
2. M. Biondi, F. Ungaro, F. Quaglia, and P. A. Netti, Controlled drug delivery in tissue engineering. Advanced Drug Delivery Reviews 60, 229 (2008).
3. F. Quaglia, Bioinspired tissue engineering: The great promise of protein delivery technologies. International Journal of Pharmaceutics 364, 281 (2008).
4. J. Taipale and J. Keski-Oja, Growth factors in the extracellular matrix. The FASEB Journal 11, 51 (1997).
5. T. A. Holland, J. K. V. Tessmar, Y. Tabata, and A. G. Mikos, Transforming growth factor-β1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. Journal of Controlled Release 94, 101 (2004).
6. F. M. Chen, Z. F. Wu, H. H. Sun, H. Wu, S. N. Xin, Q. T. Wang, G. Y. Dong, Z. W. Ma, S. Huang, Y. J. Zhang and Y. Jin, Release of bioactive BMP from dextran-derived microspheres: A novel delivery concept. International Journal of Pharmaceutics 307, 23 (2006).
7. L. Lu, G. N. Stamatas, and A. G. Mikos, Controlled release of transforming growth factor β1 from biodegradable polymer microparticles. Journal of Biomedical Materials Research 50, 440 (2000).
8. S. L. Bourke, M. Al-Khalili, T. Briggs, B. B. Michniak, J. Kohn, and L. A. Poole-Warren, A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications. AAPS PharmSci 5, 101 (2003).
9. M. Yamamoto, Y. Ikada, and Y. Tabata, Controlled release of growth factors based on biodegradation of gelatin hydrogel. Journal of Biomaterials Science, Polymer Edition 12, 77 (2001).
10. K. Y. Lee, M. C. Peters, K. W. Anderson, and D. J. Mooney, Controlled growth factor release from synthetic extracellular matrices. Nature 408, 998 (2000).
11. W. J. Li, R. L. Mauck, and R. S. Tuan, Electrospun nanofibrous scaffolds: Production, characterization, and applications for tissue engineering and drug delivery. J. Biomed. Nanotechnol. 1, 259 (2005).
12. A. Formhals, Process and apparatus for artificial threads. U.S. Patent 1,975,504, October 2 (1934).
13. G. Taylor, Disintegration of water drops in an electric field, Proceedings of the Royal Society of London. Series A. Mathematical and Physical Sciences 280, 383 (1964).
14. G. I. Taylor, Electrically driven jets. Proc. R. Soc. London, Ser. A 313, 453 (1969).
15. D. H. Reneker and I. Chun, Nanometre diameter fibres of polymer, produced by electrospinning. Nanotechnology 7, 216 (1996).
16. T. J. Sill and H. A. von Recum, Electrospinning: Applications in drug delivery and tissue engineering. Biomaterials 29, 1989 (2008).
17. Y. Ying, J. Zhidong, L. Qiang, and G. Zhicheng, Experimental investigation of the governing parameters in the electrospinning of polyethylene oxide solution. IEEE Transactions on Dielectrics and Electrical Insulation 13, 580 (2006).
18. A. K. Moghe and B. S. Gupta, Co-axial Electrospinning for Nanofiber Structures: Preparation and Applications. Polymer Reviews 48, 353 (2008).
19. Y. Z. Zhang, X. Wang, Y. Feng, J. Li, C. T. Lim, and S. Ramakrishna, Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly(ε-caprolactone) nanofibers for sustained release. Biomacromolecules 7, 1049 (2006).
20. H. Li, R. J. Hardy, and X. Gu, Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets. AAPS PharmSciTech 9, 437 (2008).
21. B. C. Anderson, N. K. Pandit, and S. K. Mallapragada, Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. J. Controlled Release 70, 157 (2001).
22. R. Baker and R. W. Baker (eds.), Controlled Release of Biologically Active Agents, Wiley, Hoboken (1987).
23. Z. Huang, E. R. Nelson, R. L. Smith, and S. B. Goodman, The sequential expression profiles of growth factors from osteroprogenitors to osteoblasts in vitro. Tissue Engineering 13, 2311 (2007).
24. I. C. Liao, S. Y. Chew, and K. W. Leong, Aligned core-shell nanofibers delivering bioactive proteins. Nanomedicine (London, England) 1, 465 (2006).
25. S. Sahoo, L. T. Ang, J. C. H. Goh, and S. L. Toh, Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications. Journal of Biomedical Materials Research-Part A 93, 1539 (2010).
26. C.-L. He, Z.-M. Huang, X.-J. Han, L. Liu, H.-S. Zhang, and L.-S. Chen, Coaxial Electrospun Poly-L-Lactic Acid Ultrafine Fibers for Sustained Drug Delivery. J. Macromol. Sci., Part B: Physics 45, 515 (2006).
27. H. Li, C. Zhao, Z. Wang, H. Zhang, X. Yuan, and D. Kong, Controlled release of PDGF-bb by coaxial electrospun dextran/poly(L-lactide-co-ε-caprolactone) fibers with an ultrafine core-shell structure. J. Biomater. Sci., Polym. Ed. 21, 803 (2010).
28. I. C. Liao and K. W. Leong, Efficacy of engineered FVIII-producing skeletal muscle enhanced by growth factor-releasing co-axial electrospun fibers. Biomaterials 32, 1669 (2011).
29. J. H. Yu, S. V. Fridrikh, and G. C. Rutledge, Production of Submicrometer Diameter Fibers by Two-Fluid Electrospinning. Adv. Mater. 16, 1562 (2004).
30. D. Li and Y. Xia, Direct fabrication of composite and ceramic hollow nanofibers by electrospinning. Nano Letters 4, 933 (2004).
31. X. Xu, X. Zhuang, X. Chen, X. Wang, L. Yang, and X. Jing, Preparation of core-sheath composite nanofibers by emulsion electrospinning. Macromolecular Rapid Communications 27, 1637 (2006).
32. Y. Yeo and K. Park, Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Archives of Pharmacal Research 27, 1 (2004).
33. X. Huang and C. S. Brazel, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Controlled Release 73, 121 (2001).
34. H. Qi, P. Hu, J. Xu, and A. Wang, Encapsulation of drug reservoirs in fibers by emulsion electrospinning: Morphology characterization and preliminary release assessment. Biomacromolecules 7, 2327 (2006).
35. W. R. Gombotz and S. Wee, Protein release from alginate matrices. Advanced Drug Delivery Reviews 31, 267 (1998).
36. J. D. Meyer and M. C. Manning, Hydrophobic ion pairing: Altering the solubility properties of biomolecules. Pharm. Res. 15, 188 (1998).
37. Y. Li, H. Jiang, and K. Zhu, Encapsulation and controlled release of lysozyme from electrospun poly(ε-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme-oleate complexes. J. Mater. Sci.: Mater. Med. 19, 827 (2008).
38. M. E. Powers, J. Matsuura, J. Brassell, M. C. Manning, and E. Shefter, Enhanced solubility of proteins and peptides in nonpolar solvents through hydrophobic ion pairing. Biopolymers 33, 927 (1993).
39. P. Tengvall, J. E. Ellingsen, and S. P. Lyngstadaas, Bio-Implant Interface, Improving Biomaterials and Tissue Reactions, CRC Press, Boca Raton (2003), pp. 285-303.
40. P. D. Drumheller and J. A. Hubbell, The Biomedical Engineering Handbook, 2nd edn., edited by J. D. Bronzino, CRC Press, Boca Raton (2000).
41. J. K. Tessmar, A. G. Mikos, and A. Göpferich, Amine-Reactive Biodegradable Diblock Copolymers. Biomacromolecules 3, 194 (2001).
42. Y. I. Cho, J. S. Choi, S. Y. Jeong, and H. S. Yoo, Nerve growth factor (NGF)-conjugated electrospun nanostructures with topographical cues for neuronal differentiation of mesenchymal stem cells. Acta Biomaterialia 6, 4725 (2010).
43. C. L. Casper, N. Yamaguchi, K. L. Kiick, and J. F. Rabolt, Functionalizing electrospun fibers with biologically relevant macromolecules. Biomacromolecules 6, 1998 (2005).
44. A. Sommer and D. B. Rifkin, Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J. Cell. Physiol. 138, 215 (1989).
45. N. N. Nissen, R. Shankar, R. L. Gamelli, A. Singh, and L. A. Dipietro, Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochemical Journal 338, 637 (1999).
46. C. L. Casper, W. Yang, M. C. Farach-Carson, and J. F. Rabolt, Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding. Biomacromolecules 8, 1116 (2007).
47. N. D. Leipzig, C. Xu, T. Zahir, and M. S. Shoichet, Functional immobilization of interferon-gamma induces neuronal differentiation of neural stem cells. Journal of Biomedical Materials Research Part A 93A, 625 (2010).
48. S. Barrientos, O. Stojadinovic, M. S. Golinko, H. Brem, and M. Tomic-Canic, PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing. Wound Repair and Regeneration 16, 585 (2008).
49. A. Schneider, X. Y. Wang, D. L. Kaplan, J. A. Garlick, and C. Egles, Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomaterialia 5, 2570 (2009).
50. S. A. Eming, H. Smola, and T. Krieg, Treatment of chronic wounds: State of the art and future concepts. Cells Tissues Organs 172, 105 (2002).
51. Y. Yang, T. Xia, W. Zhi, L. Wei, J. Weng, C. Zhang, and X. Li, Promotion of skin regeneration in diabetic rats by electrospun coresheath fibers loaded with basic fibroblast growth factor. Biomaterials 32, 4243 (2011).
52. J. S. Choi, K. W. Leong, and H. S. Yoo, In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 29, 587 (2008).
53. Ensuring access to America's orthopaedic services http://www.aaos. org/govern/public/aaos_bill/AAOSSenateCosponsor.pdf (2010).
54. S. Sahoo, L.-T. Ang, J. Cho-Hong Goh, and S.-L. Toh, Bioactive nanofibers for fibroblastic differentiation of mesenchymal precursor cells for ligament/tendon tissue engineering applications. Differentiation 79, 102 (2010).
55. M. R. Urist, Bone: Formation by Autoinduction. Science 150, 893 (1965).
56. P. C. Chang, B. Y. Liu, C. M. Liu, H. H. Chou, M. H. Ho, H. C. Liu, D. M. Wang, and L. T. Hou, Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds. Journal of Biomedical Materials Research-Part A 81, 771 (2007).
57. M. R. Johnson, H.-J. Lee, R. V. Bellamkonda, and R. E. Guldberg, Sustained release of BMP-2 in a lipid-based microtube vehicle. Acta Biomaterialia 5, 23 (2009).
58. B. Rai, S. H. Teoh, K. H. Ho, D. W. Hutmacher, T. Cao, F. Chen, and K. Yacob, The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials 25, 5499 (2004).
59. M. D. Schofer, S. Fuchs-Winkelmann, C. Gräbedünkel, C. Wack, R. Dersch, M. Rudisile, J. H. Wendorff, A. Greiner, J. R. J. Paletta, and U. Boudriot, Influence of poly(L-lactic acid) nanofibers and BMP-2-containing poly(L-lactic acid) nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells. The Scientific World Journal 8, 1269 (2008).
60. S. Srouji, D. Ben-David, R. Lotan, E. Livne, R. Avrahami, and E. Zussman, Slow-release human recombinant bone morphogenetic protein-2 embedded within electrospun scaffolds for regeneration of bone defect: In vitro and in vivo evaluation. Tissue Engineering-Part A 17, 269 (2011).
61. H. Nie, W. S. Beng, Y. C. Fu, and C. H. Wang, Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol. Bioeng. 99, 223 (2008).
62. Y.-C. Fu, H. Nie, M.-L. Ho, C.-K. Wang, and C.-H. Wang, Optimized bone regeneration based on sustained release from threedimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnol. Bioeng. 99, 996 (2008).
63. C. Li, C. Vepari, H. J. Jin, H. J. Kim, and D. L. Kaplan, Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27, 3115 (2006).
64. X. Zhu, H. Fan, D. Li, Y. Xiao, and X. Zhang, Protein adsorption and zeta potentials of a biphasic calcium phosphate ceramic under various conditions. Journal of Biomedical Materials Research Part B: Applied Biomaterials 82B, 65 (2007).
65. National Spinal Cord Injury Statistical Center http://www.spinalcord. uab.edu/show.asp?durki=116979, (2011).
66. J. Noble, C. A. Munro, V. S. S. V. Prasad, and R. Midha, Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. The Journal of Trauma 45, 116 (1998).
67. S. M. Willerth and S. E. Sakiyama-Elbert, Approaches to neural tissue engineering using scaffolds for drug delivery. Advanced Drug Delivery Reviews 59, 325 (2007).
68. L. A. Greene and A. S. Tischler, Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor, Proceedings of the National Academy of Sciences of the United States of America (1976), Vol. 73, p. 2424.
69. S. Y. Chew, J. Wen, E. K. F. Yim, and K. W. Leong, Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 6, 2017 (2005).
70. S. Yan, L. Xiaoqiang, T. Lianjiang, H. Chen, and M. Xiumei, Poly(llactide-co-ε-caprolactone) electrospun nanofibers for encapsulating and sustained releasing proteins. Polymer 50, 4212 (2009).
71. C. M. Valmikinathan, S. Defroda, and X. Yu, Polycaprolactone and bovine serum albumin based nanofibers for controlled release of nerve growth factor. Biomacromolecules 10, 1084 (2009).
72. F. Yang, R. Murugan, S. Wang, and S. Ramakrishna, Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials 26, 2603 (2005).
73. S. Y. Chew, R. Mi, A. Hoke and K. W. Leong, Aligned proteinpolymer composite fibers enhance nerve regeneration: A potential tissue-engineering platform. Adv. Funct. Mater. 17, 1288 (2007).
74. L. Ye, X. Wu, Q. Mu, B. Chen, Y. Duan, X. Geng, Y. Gu, A. Zhang, J. Zhang, and Z. G. Feng, Heparin-conjugated PCL scaffolds fabricated by electrospinning and loaded with fibroblast growth factor 2. Journal of Biomaterials Science, Polymer Edition 22, 389 (2011).